Tony Walton
Latest contributions
Lifetime management with self-expandable valve based on the latest evidence
09 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest evidence on the Evolut system and its impact on long-term valve durability in TAVR. Gain insights into its use for TAV-in-SAV procedures, the role of valve design in optimizing outcomes, and the importance of first-valve selection, commissure alignment, and coronary access.
Bicuspid and complications
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into this comprehensive session exploring the complexities of bicuspid aortic valve disease and the associated complications. Discover tailored sizing techniques for balloon-expandable valves in type 1 bicuspid, navigate the challenges of TAVR in bicuspid aortic valve type 0 with small annulus and coronary compromise, and...
Repeat TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the world of repeat TAVI in this insightful session. Gain a comprehensive understanding of the predicted surge in valve-in-valve volume, the various causes of TAVI dysfunction requiring re-intervention, and the comparative performance of balloon-expandable and self-expandable valves for percutaneous treatment of failed aortic valve...
Mitral challenging anatomy
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore this session to discover various challenging mitral valve anatomies and interventions. From unavoidable iatrogenic mitral stenosis following transcatheter edge-to-edge repair to successful procedures with the PASCAL device for severe mitral regurgitation, this session provides valuable insights into complex mitral valve cases.
Lifetime management - First valve choice matters
08 Feb 2025 – From PCR Tokyo Valves 2025
In this expert-led session, explore new frontiers in TAVI, focusing on bicuspid aortic valves, small annulus, and the risk of secondary interventions. Gain insights from the latest randomized trials (RHEIA) and registry data (CAvEAT), with real-world case discussions highlighting their clinical impact.
